This article is for informational and educational purposes only. It does not constitute medical advice. Side effect management should be discussed with your prescribing physician. If you experience severe or persistent side effects, contact your healthcare provider immediately. Compounded semaglutide is not an FDA-approved drug. Individual responses vary.
Before you start any GLP-1 program — including RNK Health's — you should know what you're likely to feel in the first few weeks. Most reviews cover the weight loss outcomes in detail and then gesture vaguely at “some GI effects” before moving on. This article doesn't do that. The side effect profile of semaglutide-class medications is well-documented, and understanding it before you start gives you two advantages: you won't be surprised when nausea hits on week two, and you'll know the difference between a normal adjustment response and something worth calling your doctor about. Both of those things matter more than any before-and-after photo.
What the Evidence Actually Shows
The most comprehensive non-trial data on real-world semaglutide and tirzepatide side effects comes from a large-scale analysis published in Nature Health examining 410,198 Reddit posts between May 2019 and June 2025, capturing self-reported experiences from over 67,000 users. This is a self-reported, observational analysis — not a controlled clinical trial — but the scale makes it meaningfully informative about what patients actually experience outside of trial conditions. The methodology and publication venue are worth noting: this is peer-reviewed research, not a survey.
Gastrointestinal symptoms predominated. Nausea was reported in approximately 37% of posts. Fatigue in approximately 17%. Vomiting in approximately 16%. Constipation in approximately 15%. Diarrhea in approximately 13%. Beyond the commonly known GI profile, the analysis also identified reproductive symptoms — including menstrual irregularities — and temperature-related complaints such as chills and hot flushes as emerging signals not well-captured in current drug labeling. These findings don't change the risk-benefit calculus for most people, but they expand what “normal range” side effects look like in the real-world experience.
From the clinical trial side: the STEP 1 trial data for semaglutide showed nausea as the most common adverse event, reported in 44% of the semaglutide group versus 16% in the placebo group. Most nausea was mild to moderate and transient — meaning it improved over time. Discontinuation due to adverse events occurred in 7% of the semaglutide group versus 3% in placebo.
Why Titration Is the Most Important Variable
The severity of GLP-1 side effects is not fixed — it's directly influenced by how quickly the dose is increased. Standard GLP-1 prescribing protocols start at the lowest available dose and increase gradually over several months. This is called titration, and it exists for a specific reason: the gastrointestinal system needs time to adapt to the medication's effects on gastric emptying and appetite signaling. Jumping to a higher dose too quickly is the most reliable way to maximize nausea and vomiting. Staying at each dose level for the prescribed period — even if you're tolerating it well and want faster results — is medically appropriate practice.
RNK Health's physician-guided structure and coaching support is relevant here. Your coach and physician can evaluate your tolerance at each dose level and adjust the titration schedule if side effects are problematic. Don't try to accelerate titration on your own. That's what the physician access is for. If you're in a program where you can't easily reach your prescribing physician when side effects are difficult, that's a structural problem with your program regardless of which provider you're using.
The Nausea Problem: Practical Management
Nausea is the side effect that causes most people to consider quitting in the first four to six weeks. A few evidence-aligned strategies are worth knowing before you start. First: eat smaller, more frequent meals rather than the three standard larger meals. GLP-1 medications slow gastric emptying, which means food sits in your stomach longer than usual — a large meal on top of a slowed system is a reliable nausea trigger. Second: avoid high-fat foods, fried foods, and very spicy foods, particularly early in treatment. Fat slows gastric emptying independently of the medication; stacking the two effects increases GI distress. Third: eat slowly and stop before you feel full. The medication is changing your satiety signals, but the sensation of fullness may lag — overeating past your new lower threshold produces nausea reliably. Fourth: stay well-hydrated, but drink between meals rather than with large meals. Fifth: keep the injection day consistent and note whether symptoms cluster around the injection window — many people find symptoms peak 24–48 hours post-injection and plan accordingly.
If nausea is severe, persistent, or accompanied by inability to keep fluids down, contact your prescribing physician. This is not a push-through situation. Dose reduction may be appropriate, and that conversation belongs with your doctor.
Constipation: The Underreported Problem
Constipation appears in approximately 15% of self-reported experiences and is underemphasized relative to nausea in most reviews. Semaglutide slows gastric motility throughout the GI tract, not just at the stomach. The practical result is slower transit time and more water absorption from stool. Staying adequately hydrated is the first line of defense — most GLP-1 users underestimate how much their water needs change on the medication. Adequate dietary fiber (from vegetables, legumes, and whole grains) supports normal transit. If constipation is significant, discuss with your physician — osmotic laxatives like polyethylene glycol (Miralax) are commonly used as a short-term adjunct and have good safety profiles at standard doses.
Fatigue: What It Means and What to Watch For
Approximately 17% of self-reported experiences mention fatigue. Some fatigue on GLP-1 therapy is expected and often reflects the body adjusting to reduced caloric intake rather than a direct medication effect. When you're eating significantly less, total energy availability drops. Protein intake becomes especially important — inadequate protein during weight loss on GLP-1 medications contributes to muscle loss and worsens fatigue. Aim for adequate protein at each meal, especially as appetite suppression makes it tempting to eat less of everything including protein.
Fatigue that's severe, sudden-onset, or accompanied by other symptoms warrants a call to your physician. Dehydration is a common culprit that's easily corrected. Thyroid issues, blood sugar changes, and other metabolic factors can also present as fatigue and deserve clinical evaluation if the symptom is persistent or severe.
Menstrual Irregularities: An Emerging Signal
The Nature Health analysis flagged menstrual irregularities as a side effect “not well captured in current labelling.” This is a real-world signal worth flagging, though the mechanism is not fully established. Rapid weight loss itself is a known cause of menstrual disruption — the relationship between body fat and hormonal regulation means significant weight change can alter cycle regularity independent of any medication effect. Whether the GLP-1 mechanism contributes beyond the weight loss effect is an open research question. If you experience significant menstrual changes on GLP-1 therapy, document them and discuss with your physician.
When to Contact Your Physician Immediately
The following symptoms require prompt medical attention — do not attempt to manage them at home or wait for your next scheduled check-in: severe and persistent abdominal pain (possible pancreatitis signal), symptoms of allergic reaction (difficulty breathing, facial swelling, rash), persistent vomiting that prevents keeping fluids down, signs of severe dehydration (extreme thirst, reduced urination, dizziness), vision changes, or a lump or swelling in the neck with difficulty swallowing (possible thyroid signal — GLP-1 medications carry a warning regarding medullary thyroid cancer risk, which is why a personal or family history of MTC is a contraindication).
Are Compounded Semaglutide Side Effects Different?
Compounded semaglutide contains the same active ingredient as Wegovy (semaglutide), so the mechanism driving side effects is identical. Compounded formulations may use different inactive ingredients, which could affect tolerability for some individuals with specific sensitivities. Because compounded semaglutide is not FDA-approved, there are no published head-to-head safety studies comparing compounded versus branded formulations in controlled settings. The side effect profile described in this article is based on data from branded semaglutide trials and real-world self-reported experiences — it is the best available proxy, but not a direct comparison.
For a full breakdown of RNK Health's program — including pricing, what's included, and how the physician oversight works — see my RNK Health review. For a deeper comparison of injectable versus oral semaglutide and tirzepatide, see my format comparison article. If you're in the early research stage and still learning how telehealth GLP-1 programs work, my beginner's guide covers the full process.
If you're weighing whether you need a prescription program at all versus a supplement-based approach, my review of Sprout Health GLP-1 covers the non-prescription alternative and what the evidence says about that category.
Frequently Asked Questions
What are the most common side effects of compounded semaglutide? Nausea (approximately 37%), fatigue (approximately 17%), vomiting (approximately 16%), constipation (approximately 15%), and diarrhea (approximately 13%), based on large-scale self-reported data and clinical trial results. Most are gastrointestinal and improve with time and careful titration.
How long do side effects last? Most intense effects occur in the first few weeks at each new dose level, then diminish as the body adjusts. Slow titration significantly reduces severity and duration.
Can you prevent semaglutide nausea? You can reduce it substantially: smaller meals, avoiding high-fat and spicy foods, staying hydrated, eating slowly, and following the prescribed titration schedule. It cannot always be fully prevented, particularly in the early weeks.
Are compounded semaglutide side effects different from branded Wegovy? Same active ingredient, same mechanism. Different inactive ingredients are possible and could affect tolerability. No published head-to-head safety comparison exists for compounded versus branded formulations.